期刊文献+

秦皇岛两所医院2006~2010年金黄色葡萄球菌耐药性分析 被引量:5

暂未订购
导出
摘要 目的分析金黄色葡萄球菌(SA)耐药性的变化,调查SA感染分布,耐甲氧西林金黄色葡萄球菌(MRSA)检出动态及其对万古霉素药物敏感情况。方法收集秦皇岛2家医院2006~2010年临床标本中分离的SA菌株,鉴定、药敏试验及MRSA鉴定采用黑马细菌分析系统,用微量肉汤稀释法监测MRSA的万古霉素最低抑制浓度(MIC)值变化。结果 SA对各种抗菌药物的耐药率呈逐年上升趋势,MRSA5年分离率为61.3%。MRSA的检出率逐年升高,2010年与2006年比较,MRSA的检出率差异有统计学意义。MRSA的万古霉素MIC值5年间差异无统计学意义。重症监护病房(ICU)是产MRSA的高危病区。结论 5年间SA耐药率持续保持较高的水平,MRSA检出率显著升高应引起临床和实验室高度重视。
出处 《医药导报》 CAS 北大核心 2013年第1期28-30,共3页 Herald of Medicine
  • 相关文献

参考文献11

二级参考文献88

共引文献147

同被引文献58

  • 1Hodle AE, Richter KP,Thompson RM. Infection control prac- tices in U.S.burn units [J]. Journal of Bum Care & Research, 2006,27(2) : 143-150.
  • 2Guggenheim M, Zbinden R, Handschin AE,et al. Changes in bacterial isolates from burn wounds and their antibio- grams: A 20-year study (1986 - 2005) [J]. Burns,2009, 35(4) :554-555.
  • 3Fadeyibi IO,Raji MA,Ibrahim NA,et al. Bacteriology of infected burn wounds in the burn wards of a teaching hospital in Southwest Nigeria [J]. Bums,2013,39 (1) : 171.
  • 4ZHANG L, CHEN J,HAN C. A multicenter clinical trial ofrecombinant human GM-CSF hydrogel for the treatment ofdeep second-degree bums [ J ] . Wound Repair Regen, 2009,17(5) :685-689.
  • 5YAN H, CHEN J, PENG X. Recombinant human granulo-cyte-macrophage colonystimulating factor hydrogel promoteshealing of deep partial thickness bum wounds [ J]. Bums,2012,38(6) :877-881.
  • 6CHEN X D,SHI Y,SHU B,et al. The effect of porcine ADMto improve the bum wound healing [ J ]. Int J Clin ExpPathol,2013,6(11) :2280-2291.
  • 7HAN Y, SHAO Y, LIN Z H, et al. Netrin-1 simultaneouslysuppresses comeal inflammation and neovascularization[J]. Invest Ophthalmol Vis Sci ,2012,53 (3) :1285-1295.
  • 8LIU H, LIN S,XIA0 D, et al. Evaluation of the woundhealing potential of resina draconis ( dracaenacochinchinensis) in animal models [ J ]. Evid BasedComplement Altemat Med,2013,ID :709865 :8.
  • 9ZHANG Z, FINNERTY C C, HE J. Smad ubiquitinationregulatory factor 2 expression is enhanced in hypertrophicscar fibroblasts from burned children[ J]. Bums,2012,38(2):236-246.
  • 10Clinical and Ladoratory Standards Institute. Performance Standards for Antimicrobial Susceptibility testing[S]. M100-S20. CLSI, 2010.

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部